Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
CMPX
Shares outstanding
138,157,900 shares
Disclosed Ownership
11,052,632 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:15:24 UTC
Date of event
31 Mar 2025
Previous filing
16 Jan 2025
Next filing
14 Aug 2025

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 8% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 31 Mar 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
  • Disclosed ownership: 8%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 16 Jan 2025.
  • Current filing was accepted on 15 May 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 8% 11,052,632 0 11,052,632 /s/ Kevin Tang Manager
KEVIN TANG 8% 11,052,632 0 11,052,632 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 4% 5,391,171 0 5,391,171 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 3.1% 4,328,461 0 4,328,461 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0.7% 999,750 0 999,750 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0.2% 333,250 0 333,250 /s/ Kevin Tang Chief Executive Officer